Skip to main content

Narcolepsy and Mental Health

  • Chapter
  • First Online:
Narcolepsy

Abstract

There are methodological difficulties in assessing cognitive function in narcolepsy, but despite these it appears that there is a defect in maintenance of attention, which is more significant than the problems with memory. The subject’s perception of memory loss is however greater than what can be demonstrated objectively. There may also be a generalised executive dysfunction unrelated to attention and memory deficits. Anxiety and depression are common, particularly in younger subjects. Psychosis is usually drug-induced, particularly by amphetamines. The realistic dreams and hypnagogic hallucinations should be distinguished from schizophrenia and REM sleep behaviour disorder.

There is considerable functional impairment due to the symptoms of narcolepsy with reduced quality of life, particularly in the domains of vitality and physical roles. Changes with age are probably important, but there are only few differences between the genders. Education, performance at work, social and recreational activities are all impaired by narcolepsy, but attention to lifestyle aspects and treatment with modern drugs, particularly modafinil and sodium oxybate, can improve functional capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schneider C, Fulda S, Schulz H. Daytime variation in performance and tiredness/sleepiness ratings in patients with insomnia, narcolepsy, sleep apnea and normal controls. J Sleep Res 2004;13:373–383

    Article  CAS  PubMed  Google Scholar 

  2. Hood B, Bruck D. Sleepiness and performance n narcolepsy. J Sleep Res 1996;5:128–134

    Article  CAS  PubMed  Google Scholar 

  3. Pollak CP, Wagner DR, Moline ML, et al. Cognitive and motor performance of narcoleptic and normal subjects living in temporal isolation. Sleep 1992;15:202–211

    CAS  PubMed  Google Scholar 

  4. Valley V, Broughton R. Daytime performance deficits and physiological vigilance n untreated patients with narcolepsy-cataplexy compared with controls. Rev EEG Neurophysiol 1981;11:133–139

    CAS  Google Scholar 

  5. Schulz H, Wilde-Frenz J. The disturbance of cognitive processes in narcolepsy. J Sleep Res 1995;4:10–14

    Article  PubMed  Google Scholar 

  6. Rieger M, Mayer G, Gauggel S. Attention deficits in patients with narcolepsy. Sleep 2003;26:36–43

    PubMed  Google Scholar 

  7. Naumann A, Bellebaum C, Daum I. Cognitive deficits in narcolepsy. J Sleep Res 2006;15:329–338

    Article  CAS  PubMed  Google Scholar 

  8. Godbout R, Montplaisir J. All-day performance variations in normal and narcoleptic subjects. Sleep 1986;9:200–204

    CAS  PubMed  Google Scholar 

  9. Broughton RJ, Ghanem Q, Hishikawa Y, et al. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 1981;8:299–304

    CAS  PubMed  Google Scholar 

  10. Smith KM, Merritt SL, Cohen FL. Can we predict cognitive impairments in persons with narcolepsy? Loss Grief Care 1992;5:103–113

    Google Scholar 

  11. Aguirre M, Broughton R, Stuss D. Does memory impairment exist in narcolepsy-cataplexy? J Clin Exp Neuropsychol 1985;7:14–24

    Article  CAS  PubMed  Google Scholar 

  12. Rogers AE, Rosenberg RS. Tests of memory in narcoleptics. Sleep 1990;13:42–52

    CAS  PubMed  Google Scholar 

  13. Henry GK, Satz P, Heilbronner RL. Evidence of a perceptual-encoding deficit in narcolepsy? Sleep 1993;16:123–127

    Google Scholar 

  14. Hood B, Bruck D. Metamemory in narcolepsy. J Sleep Res 1997;6:205–210

    Article  CAS  PubMed  Google Scholar 

  15. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423–445

    Article  PubMed  Google Scholar 

  16. Naumann A, Daum I. Narcolepsy: pathophysiology and neuropsychological changes. Behav Neurol 2003;14:89–98

    PubMed  Google Scholar 

  17. Stores G. The protean manifestations of childhood narcolepsy and their misinterpretation. Dev Med Child Neurol 2006;48:307–310

    Article  PubMed  Google Scholar 

  18. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res 2001;10:75–81

    Article  CAS  PubMed  Google Scholar 

  19. Dodel R, Peter H, Walbert T , Spottke A, Noelker C, Berger K, Siebert U, Oertel WH, Kesper K, Becker HF, Mayer G. The socioeconomic impact of narcolepsy. Sleep 2004;27:1123–1128

    PubMed  Google Scholar 

  20. Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 2006;e1116–e1123

    Google Scholar 

  21. Shneerson JM, Myers AJ, Morrish E. Factors determining quality of life in narcolepsy. In preparation

    Google Scholar 

  22. Vourdas A, Shneerson JM, Gregory CA, Smith IE, King MA, Morrish E, McKenna PJ. Narcolepsy and psychopathology: is there an association? Sleep Med 2002;3:353–360

    Article  CAS  PubMed  Google Scholar 

  23. Fosse R, Stickgold R, Hobson JA. Emotional experience during rapid-eye-movement sleep in narcolepsy. Sleep 2002;25:724–730

    PubMed  Google Scholar 

  24. Schenck CH, Mahwold MW. REM sleep behavior disorder: Clinical, developmental and neuroscience perspectives 16 years after its formal identification in sleep. Sleep 2002;25:120–138

    PubMed  Google Scholar 

  25. Ervik S, Abdelnoor M, Heier MS, Ramberg M, Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand 2006;e114:198–204

    Google Scholar 

  26. Dodel R, Peter H, Spottke A, Noelker C, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-related quality of life in patients with narcolepsy. Sleep Med 2007;8:733–741

    Article  PubMed  Google Scholar 

  27. Shneerson JM, Dauvilliers Y, Garcia-Borreguero D, Plazzi G. The impact of narcolepsy and its treatment – a European Study. Eur J of Neurol 2008 submitted for publication

    Google Scholar 

  28. Vignatelli L, D’Alessandro R, Mosconi P, Ferini-Strambi L, Guidolin L, De Vincentiis A, Plazzi G. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med 2004;5:467–475

    Article  PubMed  Google Scholar 

  29. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;6:757–765

    Google Scholar 

  30. Lamphere J, Young D, Roehrs T, et al. Fragmented sleep, daytime somnolence and age in narcolepsy. Clin Electroencephalogr 1989;20:49–54

    CAS  PubMed  Google Scholar 

  31. Quinnell TQ, Smith IE, Shneerson JM. Impact of age on narcolepsy: evidence for an accelerated decline in nocturnal sleep quality. J Clin Sleep Med 2008 submitted for publication

    Google Scholar 

  32. Wittig R, Zorick F, Piccione P, Sicklesteel J, Roth T. Narcolepsy and disturbed nocturnal sleep. Clin Electroencephalogr 1983;14:130–134

    CAS  PubMed  Google Scholar 

  33. Dauvilliers Y, Pennestri M-H, Petit D, Dang-Vu T, Lavigne G, Montplaisir J. Periodic leg movements during sleep and wakefulness in narcolepsy. J Sleep Res 2007;16:333–339

    Article  PubMed  Google Scholar 

  34. Billiard M, Besset A, Cadilhac J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven, 1983:171–185

    Google Scholar 

  35. Passouant P, Billiard M. The evolution of narcolepsy with age. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum, 1976;176–196

    Google Scholar 

  36. Rosenthal LD, Merlotti L, Young DK, et al. Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy. Gen Hosp Psychiatry 1990;191–197

    Google Scholar 

  37. Dauvilliers Y, Gosselin A, Paquet J, et al. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 2004;61:46–50

    Google Scholar 

  38. Nevsimalova S, Vankova J, Pretl M, Bruck D. Narkolepsie v detsckem a adolescentnim veku-klinicke a psychosocialni aspekty. Ces a slov Neurol Neurochir 2002;3:169–174

    Google Scholar 

  39. Wise MS. Childhood narcolepsy. Neurology 1998;50:S37–S42

    CAS  PubMed  Google Scholar 

  40. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 1998;50:S31–S36

    CAS  PubMed  Google Scholar 

  41. Zwicker J, Bruck D, Parkes JD, et al. Acute mood improvement after amphetamine and methylphenidate in narcolepsy. J Sleep Res 1995;4:252–255

    Article  PubMed  Google Scholar 

  42. Schwartz JRL, Nelson MT, Schwartz ER, et al. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin Neuropharmacol 2004;27:74–79

    Article  CAS  PubMed  Google Scholar 

  43. Shneerson J, Randall D, Cafferty F, et al. Treatment with modafinil may have beneficial effects on planning ability and mood in patients with excessive daytime sleepiness: findings from a pilot study. J Sleep Res 2006;15:P029

    Google Scholar 

  44. Saletu M, Anderer P, Semlitsch HV, et al. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Psychiatry Res 2007;154:69–84

    Google Scholar 

  45. Becker PM, Schwartz JRL, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology 2004;171:133–139

    Article  CAS  PubMed  Google Scholar 

  46. The Xyrem® International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391–397

    Google Scholar 

  47. The US Xyrem® Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42–49

    Google Scholar 

  48. Weaver TE, Cuellar N. A randomized trail evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006;29:1189–1194

    PubMed  Google Scholar 

  49. Hayduk R, Mitler A. Sodium oxybate therapy improves the quality of life of narcolepsy patients. Sleep 2001;24:A326

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Shneerson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shneerson, J. (2010). Narcolepsy and Mental Health. In: Goswami, M., Pandi-Perumal, S., Thorpy, M. (eds) Narcolepsy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0854-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0854-4_22

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0853-7

  • Online ISBN: 978-1-4419-0854-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics